Gabelli & Co Investment Advisers’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio IDIX Stock Details IDIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-584,480	Closed	-$14.1M	–	193
2014 Q2	$14.1M	Buy	+584,480	New	+$6.09M	3.04%	7

Gabelli & Co Investment Advisers's IDIX Position: Q3 2014 in Review

Gabelli & Co Investment Advisers sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 584,480 shares — an estimated $14.1M sold.

Gabelli & Co Investment Advisers first reported a position in IDIX in Q2 2014 and held it in 1 quarter. The position peaked at $14.1M in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

Gabelli & Co Investment Advisers reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 584,480 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $14.1M.
Gabelli & Co Investment Advisers first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2014 and held it in 1 quarter.
Gabelli & Co Investment Advisers's IDENIX PHARMACEUTICALS INC position peaked at $14.1M in Q2 2014.
0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Gabelli & Co Investment Advisers's 13F filing for Q3 2014, filed 30 Oct 2014.